Rhynchophylline-encapsulating core-shell nanoparticles to overcome blood-brain-barrier and inhibit drug efflux for efficient anti-Parkinson therapy
Applied Materials Today · 2023-02 · 30 · 101715
DOI: 10.1016/j.apmt.2022.101715 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Materials Today, 2023-02. Verfasst von Lukuan Xie und 7 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Postdoctoral Research Foundation of China, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Postdoctoral Research Foundation of China
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Natural Science Foundation of Jiangsu Province
- Natural Science Foundation of Shandong Province
Zitieren
APA
Xie, L., Lin, H., Lv, L., Zhang, W., Feng, F., Liu, F., Liu, W., & Han, L. (2023). Rhynchophylline-encapsulating core-shell nanoparticles to overcome blood-brain-barrier and inhibit drug efflux for efficient anti-Parkinson therapy. Applied Materials Today, 30, 101715. https://doi.org/10.1016/j.apmt.2022.101715
Vancouver
Xie L, Lin H, Lv L, Zhang W, Feng F, Liu F, et al. Rhynchophylline-encapsulating core-shell nanoparticles to overcome blood-brain-barrier and inhibit drug efflux for efficient anti-Parkinson therapy. Applied Materials Today. 2023;30:101715. doi:10.1016/j.apmt.2022.101715
BibTeX
@article{Xie2023,
author = {Xie, Lukuan and Lin, Honglei and Lv, Lingrui and Zhang, Wenxin and Feng, Feng and Liu, Fulei and Liu, Wenyuan and Han, Lingfei},
title = {Rhynchophylline-encapsulating core-shell nanoparticles to overcome blood-brain-barrier and inhibit drug efflux for efficient anti-Parkinson therapy},
journal = {Applied Materials Today},
year = {2023},
volume = {30},
pages = {101715},
doi = {10.1016/j.apmt.2022.101715}
}
EUVIMED